Targeting PGLYRP1 in cancer and autoimmunity
Nat Immunol
.
2023 Nov;24(11):1785-1786.
doi: 10.1038/s41590-023-01649-0.
Authors
Carson E Moseley
1
2
,
Scott S Zamvil
3
4
Affiliations
1
Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
2
Program in Immunology, University of California, San Francisco, CA, USA.
3
Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA. zamvil@ucsf.neuroimmunol.org.
4
Program in Immunology, University of California, San Francisco, CA, USA. zamvil@ucsf.neuroimmunol.org.
PMID:
37828380
DOI:
10.1038/s41590-023-01649-0
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Autoimmunity*
Cytokines
Humans
Neoplasms*
Substances
Cytokines
PGLYRP1 protein, human